Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular fluid osmolarity refers to the concentration of osmotically active solutes (primarily sodium and its associated anions) in the extracellular compartment. It is critical for maintaining proper cellular function, fluid movement, and electrolyte balance. The kidneys, through the selective reabsorption and excretion of sodium and water under the influence of hormones such as vasopressin, aldosterone, and natriuretic peptides, play a central role in regulating ECF osmolarity[2][3][5][6]. Systemic osmoregulation ensures that cellular environments remain stable, preventing osmotic injury; disturbances in ECF osmolarity underlie various clinical disorders, particularly involving fluid and electrolyte states such as dehydration, hyponatremia, or hypernatremia[2][4].
Drugs may alter ECF osmolarity by increasing or decreasing renal water and/or sodium reabsorption/excretion[2][5][6]. Antidiuretic hormone analogs promote water retention and lower ECF osmolarity[2]. Diuretics promote water/sodium excretion, potentially affecting ECF volume and osmolarity[6]. Hyperosmolar agents (e.g., mannitol) draw fluid from cells into ECF[2].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular fluid osmolarity.